Nigeria Set to Receive New HIV Prevention Drug in March

2 March 2026
Leadership (Abuja)
By Patience Ivie Ihejirika

The National Agency for the Control of AIDS (NACA) has said that Nigeria will receive its first shipment of Lenacapavir (LEN), a twice-yearly HIV prevention drug, by March 2026.

NACA, in a statement on Monday said the federal government was finalising preparations for the introduction and rollout of the injectable Pre-Exposure Prophylaxis (PrEP) option as part of its broader commitment to strengthen HIV prevention and accelerate progress toward epidemic control.

Lenacapavir, taken only twice a year, is expected to provide a more convenient and effective alternative for individuals at high risk of HIV.

NACA said Nigeria is on track for a phased introduction of LEN PrEP across priority states, backed by regulatory approval, system readiness, trained personnel, and community engagement strategies.

The federal government has already completed major rollout requirements, including landscape and readiness assessments across 10 states: Akwa Ibom, Anambra, Benue, Cross River, Ebonyi, the Federal Capital Territory, Gombe, Kano, Kwara, and Lagos, the statement stated.

NACA said it has also developed Information, Education and Communication (IEC) materials to support public awareness and smooth implementation.

Read the original article on Leadership.

Tagged:
Copyright © 2026 Leadership. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 600 reports a day from more than 90 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.